Multiparametric MRI-based radiomic models for early prediction of response to neoadjuvant systemic therapy in triple-negative breast cancer.

Rania M Mohamed, Bikash Panthi, Beatriz E Adrada, Medine Boge, Rosalind P Candelaria, Huiqin Chen, Mary S Guirguis, Kelly K Hunt, Lei Huo, Ken-Pin Hwang, Anil Korkut, Jennifer K Litton, Tanya W Moseley, Sanaz Pashapoor, Miral M Patel, Brandy Reed, Marion E Scoggins, Jong Bum Son, Alastair Thompson, Debu Tripathy, Vicente Valero, Peng Wei, Jason White, Gary J Whitman, Zhan Xu, Wei Yang, Clinton Yam, Jingfei Ma, Gaiane M Rauch
Author Information
  1. Rania M Mohamed: Department of Breast Imaging, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, # 1473, Houston, TX, 77030, USA.
  2. Bikash Panthi: Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  3. Beatriz E Adrada: Department of Breast Imaging, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, # 1473, Houston, TX, 77030, USA.
  4. Medine Boge: Department of Breast Imaging, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, # 1473, Houston, TX, 77030, USA.
  5. Rosalind P Candelaria: Department of Breast Imaging, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, # 1473, Houston, TX, 77030, USA.
  6. Huiqin Chen: Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  7. Mary S Guirguis: Department of Breast Imaging, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, # 1473, Houston, TX, 77030, USA.
  8. Kelly K Hunt: Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  9. Lei Huo: Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  10. Ken-Pin Hwang: Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  11. Anil Korkut: Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  12. Jennifer K Litton: Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  13. Tanya W Moseley: Department of Breast Imaging, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, # 1473, Houston, TX, 77030, USA.
  14. Sanaz Pashapoor: Department of Breast Imaging, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, # 1473, Houston, TX, 77030, USA.
  15. Miral M Patel: Department of Breast Imaging, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, # 1473, Houston, TX, 77030, USA.
  16. Brandy Reed: Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  17. Marion E Scoggins: Department of Breast Imaging, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, # 1473, Houston, TX, 77030, USA.
  18. Jong Bum Son: Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  19. Alastair Thompson: Department of Surgery, Baylor College of Medicine, Houston, TX, USA.
  20. Debu Tripathy: Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  21. Vicente Valero: Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  22. Peng Wei: Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  23. Jason White: Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  24. Gary J Whitman: Department of Breast Imaging, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, # 1473, Houston, TX, 77030, USA.
  25. Zhan Xu: Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  26. Wei Yang: Department of Breast Imaging, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, # 1473, Houston, TX, 77030, USA.
  27. Clinton Yam: Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  28. Jingfei Ma: Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  29. Gaiane M Rauch: Department of Breast Imaging, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, # 1473, Houston, TX, 77030, USA. GMRauch@mdanderson.org.

Abstract

Triple-negative breast cancer (TNBC) is often treated with neoadjuvant systemic therapy (NAST). We investigated if radiomic models based on multiparametric Magnetic Resonance Imaging (MRI) obtained early during NAST predict pathologic complete response (pCR). We included 163 patients with stage I-III TNBC with multiparametric MRI at baseline and after 2 (C2) and 4 cycles of NAST. Seventy-eight patients (48%) had pCR, and 85 (52%) had non-pCR. Thirty-six multivariate models combining radiomic features from dynamic contrast-enhanced MRI and diffusion-weighted imaging had an area under the receiver operating characteristics curve (AUC) > 0.7. The top-performing model combined 35 radiomic features of relative difference between C2 and baseline; had an AUC = 0.905 in the training and AUC = 0.802 in the testing set. There was high inter-reader agreement and very similar AUC values of the pCR prediction models for the 2 readers. Our data supports multiparametric MRI-based radiomic models for early prediction of NAST response in TNBC.

Keywords

References

Oncotarget. 2017 Jan 3;8(1):1913-1924 [PMID: 27765921]
Radiology. 2018 Dec;289(3):618-627 [PMID: 30179110]
Breast Cancer Res. 2016 Jul 22;18(1):76 [PMID: 27449059]
J Magn Reson Imaging. 2018 Feb;47(2):301-315 [PMID: 28639300]
Cancers (Basel). 2023 Feb 06;15(4): [PMID: 36831368]
Radiology. 2017 Mar;282(3):665-675 [PMID: 27700229]
Sci Rep. 2015 Dec 07;5:17787 [PMID: 26639025]
J Magn Reson Imaging. 2016 Nov;44(5):1107-1115 [PMID: 27080586]
Eur J Cancer. 2012 Mar;48(4):441-6 [PMID: 22257792]
J Magn Reson Imaging. 2022 Dec;56(6):1901-1909 [PMID: 35499264]
Cancer. 2016 Mar 1;122(5):748-57 [PMID: 26619259]
Clin Cancer Res. 2019 Jun 15;25(12):3538-3547 [PMID: 30842125]
N Engl J Med. 2020 Feb 27;382(9):810-821 [PMID: 32101663]
J Clin Oncol. 2008 Mar 10;26(8):1275-81 [PMID: 18250347]
Invest Radiol. 2015 Apr;50(4):195-204 [PMID: 25360603]
Radiol Imaging Cancer. 2023 Jul;5(4):e230009 [PMID: 37505106]
J Clin Oncol. 2013 Nov 1;31(31):3997-4013 [PMID: 24101045]
J Clin Oncol. 2012 May 20;30(15):1796-804 [PMID: 22508812]
Cancer Med. 2014 Jun;3(3):462-71 [PMID: 24573979]
Radiology. 2015 Aug;276(2):360-70 [PMID: 25751227]
Breast Cancer Res. 2015 May 19;17:67 [PMID: 25986460]
J Magn Reson Imaging. 2024 Jan 31;: [PMID: 38294179]
Clin Transl Oncol. 2020 Jan;22(1):50-59 [PMID: 30977048]
J Clin Oncol. 2011 Feb 20;29(6):660-6 [PMID: 21220595]
Eur Radiol. 2019 May;29(5):2535-2544 [PMID: 30402704]
Radiology. 2014 Jul;272(1):91-9 [PMID: 24620909]
Eur Radiol. 2020 Mar;30(3):1436-1450 [PMID: 31786616]
N Engl J Med. 2010 Nov 11;363(20):1938-48 [PMID: 21067385]
Sci Rep. 2023 Jan 20;13(1):1171 [PMID: 36670144]
Clin Cancer Res. 2019 Mar 15;25(6):1756-1765 [PMID: 30647080]
Invest New Drugs. 2023 Jun;41(3):391-401 [PMID: 37043123]
J Comput Assist Tomogr. 2020 Mar/Apr;44(2):275-283 [PMID: 32004189]
Am J Transl Res. 2021 May 15;13(5):4422-4436 [PMID: 34150024]
Breast Cancer Res Treat. 2023 Jun;199(3):457-469 [PMID: 37061619]
Radiology. 2016 Nov;281(2):382-391 [PMID: 27144536]
Chin J Cancer Res. 2018 Aug;30(4):432-438 [PMID: 30210223]
Br J Radiol. 2020 Nov 01;93(1115):20200287 [PMID: 32822542]

MeSH Term

Humans
Triple Negative Breast Neoplasms
Female
Neoadjuvant Therapy
Middle Aged
Multiparametric Magnetic Resonance Imaging
Adult
Aged
Treatment Outcome
ROC Curve
Magnetic Resonance Imaging
Radiomics

Word Cloud

Similar Articles

Cited By